Back to results
US 11,155,832 B2Granted
Adenovectors for delivery of therapeutic genetic material into T cells
AssigneeGenVec, Inc.
InventorsSebastien M. Maloveste, Damodar Ettyreddy, Douglas E. Brough
Life of this patent
Estimating the term…
Abstract
The invention provides adenoviral vectors and compositions for the highly efficient transduction of T cells.
Claims33
A serotype 28 adenoviral vector comprising (i) at least a portion of an adenovirus serotype 26 fiber protein in place of at least a portion of a corresponding endogenous serotype 28 fiber protein and (ii) an exogenous nucleic acid sequence.
Dependencies are inferred from the claim text.